The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Questioning the use of PEGylation for drug delivery
Open accessAbstract
Polyethylene glycol (PEG) is widely utilized in drug delivery and nanotechnology due to its reported “stealth” properties and biocompatibility. It is generally thought that PEGylation allows particulate delivery systems and biomaterials to evade the immune system and thereby prolong circulation lifetimes. However, numerous studies over the past decade have demonstrated that PEGylation causes significant reductions in drug delivery, including enhanced serum protein binding, reduced uptake by target cells, and the elicitation of an immune response that facilitates clearance in vivo. This report reviews some of the extensive literature documenting the detrimental effects of PEGylation, and thereby questions the wisdom behind employing this strategy in drug development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Fang, J., Nakamura, H., & Maeda, H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.04.009 · Cited by 3,559
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Knop, K., Hoogenboom, R., Fischer, D., & Schubert, U. S. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200902672 · Cited by 3,533 · cited 4×
“It follows that strategies to avoid liver clearance and enhance circulation lifetimes have been pursued, and the attachment of low molecular weight PEG (2–5 kDa) has been demonstrated to extend blood half-life of many nanoparticles [1].”
BackgroundResultInfluentialBiodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,920
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
Targeted drug delivery to tumors: Myths, reality and possibility
Bae, Y. H., & Park, K. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.001 · Cited by 1,935
Gref, R., Lück, M., Quellec, P., Marchand, M., Dellacherie, E., Harnisch, S., Blunk, T., & Müller, R. H. (2000) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00156-3 · Cited by 1,723
Papahadjopoulos, D., Allen, T. M., Gabizon, A., Mayhew, E., Matthay, K., Huang, S. K., Lee, K. D., Woodle, M. C., Lasic, D. D., & Redemann, C. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11460 · Cited by 1,620
Moghimi, S. M., & Szebeni, J. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00033-x · Cited by 1,227
Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes
Cerutti, A., Cols, M., & Puga, I. (2013) · Nature Reviews Immunology · doi:10.1038/nri3383 · Cited by 777
Mishra, S., Webster, P., & Davis, M. E. (2004) · European Journal of Cell Biology · doi:10.1078/0171-9335-00363 · Cited by 730
Armstrong, J. K., Hempel, G., Koling, S., Chan, L. S., Fisher, T., Meiselman, H. J., & Garratty, G. (2007) · Cancer · doi:10.1002/cncr.22739 · Cited by 699
Garay, R. P., El-Gewely, R., Armstrong, J. K., Garratty, G., & Richette, P. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.720969 · Cited by 587
Ishida, T., Ichihara, M., Wang, X., Yamamoto, K., Kimura, J., Majima, E., & Kiwada, H. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.01.005 · Cited by 557
Factors Controlling Nanoparticle Pharmacokinetics: An Integrated Analysis and Perspective
Moghimi, S. M., Hunter, A. C., & Andresen, T. L. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134623 · Cited by 545
Fang, C., Shi, B., Pei, Y.-Y., Hong, M.-H., Wu, J., & Chen, H.-Z. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.08.002 · Cited by 424
Wang, X., Ishida, T., & Kiwada, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.02.010 · Cited by 421
Semple, S. C., Chonn, A., & Cullis, P. R. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00128-2 · Cited by 402
Hatakeyama, H., Akita, H., Kogure, K., Oishi, M., Nagasaki, Y., Kihira, Y., Ueno, M., Kobayashi, H., Kikuchi, H., & Harashima, H. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302843 · Cited by 398
PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner
Ishida, T., Wang, X., Shimizu, T., Nawata, K., & Kiwada, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.015 · Cited by 382
Ishida, T., Harada, M., Wang, X. Y., Ichihara, M., Irimura, K., & Kiwada, H. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.04.003 · Cited by 365
Allen, T. M., Austin, G. A., Chonn, A., Lin, L., & Lee, K. C. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90268-d · Cited by 345
Dos Santos, N., Allen, C., Doppen, A.-M., Anantha, M., Cox, K. A. K., Gallagher, R. C., Karlsson, G., Edwards, K., Kenner, G., Samuels, L., et al. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.12.013 · Cited by 341
The Immunogenicity of Polyethylene Glycol: Facts and Fiction
Schellekens, H., Hennink, W. E., & Brinks, V. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1067-7 · Cited by 340
Hong, K., Zheng, W., Baker, A., & Papahadjopoulos, D. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01397-x · Cited by 317
Ishida, T., Atobe, K., Wang, X., & Kiwada, H. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.017 · Cited by 287
Hamad, I., Al-Hanbali, O., Hunter, A. C., Rutt, K. J., Andresen, T. L., & Moghimi, S. M. (2010) · ACS Nano · doi:10.1021/nn101990a · Cited by 276
Ishida, T., Ichihara, M., Wang, X., & Kiwada, H. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.001 · Cited by 270
Xu, L., & Anchordoquy, T. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22243 · Cited by 209
Ambegia, E., Ansell, S., Cullis, P., Heyes, J., Palmer, L., & MacLachlan, I. (2005) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2005.02.001 · Cited by 202
Moein Moghimi, S., Hamad, I., Andresen, T. L., Jørgensen, K., Szebeni, J., Moein Moghimi, S., Hamad, I., Andresen, T. L., Jørgensen, K., & Szebeni, J. (2006) · The FASEB Journal · doi:10.1096/fj.06-6186fje · Cited by 201
Accelerated Blood Clearance Phenomenon Upon Repeated Injection of PEG-modified PLA-nanoparticles
Ishihara, T., Takeda, M., Sakamoto, H., Kimoto, A., Kobayashi, C., Takasaki, N., Yuki, K., Tanaka, K.-I., Takenaga, M., Igarashi, R., et al. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9943-x · Cited by 195
Yan, X., Scherphof, G. L., & Kamps, J. A. A. M. (2005) · Journal of Liposome Research · doi:10.1081/lpr-200064971 · Cited by 187
Role of the methoxy group in immune responses to mPEG-protein conjugates
Sherman, M. R., Williams, L. D., Sobczyk, M. A., Michaels, S. J., & Saifer, M. G. P. (2012) · Bioconjugate Chemistry · doi:10.1021/bc200551b · Cited by 185
Moghimi, S. M., Andersen, A. J., Hashemi, S. H., Lettiero, B., Ahmadvand, D., Hunter, A. C., Andresen, T. L., Hamad, I., & Szebeni, J. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.04.003 · Cited by 167
Liposomes in the therapy of infectious diseases and cancer
Borek, F. (1990) · Journal of Immunological Methods · doi:10.1016/0022-1759(90)90331-o · Cited by 165
Koide, H., Asai, T., Hatanaka, K., Akai, S., Ishii, T., Kenjo, E., Ishida, T., Kiwada, H., Tsukada, H., & Oku, N. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.03.022 · Cited by 157
Effect of PEGylation on Biodistribution and Gene Silencing of siRNA/Lipid Nanoparticle Complexes
Bao, Y., Jin, Y., Chivukula, P., Zhang, J., Liu, Y., Liu, J., Clamme, J., Mahato, R. I., Ng, D., Ying, W., et al. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0874-6 · Cited by 127
Leroux, J., Jaeghere, F. D., Anner, B. M., Doelker, É., & Gurny, R. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00321-v · Cited by 127
Suzuki, T., Ichihara, M., Hyodo, K., Yamamoto, E., Ishida, T., Kiwada, H., Ishihara, H., & Kikuchi, H. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.07.049 · Cited by 127
Ishida, T., Kashima, S., & Kiwada, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.11.009 · Cited by 125
Hamad, I. M., Hunter, A. C., Rutt, K. J., Liu, Z., Dai, H., & Moghimi, S. M. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.05.020 · Cited by 123
Johnstone, S. A., Masin, D., Mayer, L. D., & Bally, M. B. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00292-9 · Cited by 120
The role of lipid charge density in the serum stability of cationic lipid/DNA complexes
Zhang, Y., & Anchordoquy, T. J. (2004) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2004.03.004 · Cited by 120
Self-citationRepeated injections of PEG-PE liposomes generate anti-PEG antibodies.
Środa-Pomianek, K., Rydlewski, J., Langner, M., Kozubek, A., Grzybek, M., & Sikorski, A. F. (2005) · PubMed · Cited by 116
Laverman, P., Brouwers, A. H., Dams, E. T. M., Oyen, W. J. G., Storm, G., van Rooijen, N., Corstens, F. H. M., & Boerman, O. C. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39325-5 · Cited by 113
Shimizu, T., Ichihara, M., Yoshioka, Y., Ishida, T., Nakagawa, S., & Kiwada, H. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-00276 · Cited by 106
Shimizu, T., Ishida, T., & Kiwada, H. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.08.274 · Cited by 94
Therapeutic synthetic polymers: a game of Russian roulette?
Hunter, A. C., & Moghimi, S. M. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02444-3 · Cited by 83
Cholesterol domains in cationic lipid/DNA complexes improve transfection
Xu, L., & Anchordoquy, T. J. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.04.009 · Cited by 81
Self-citationAnti-polyethyleneglycol Antibody Response to PEGylated Substances
Ishida, T., & Kiwada, H. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b13-00107 · Cited by 78
Liposomes in the therapy of infectious diseases and cancer
(1988) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240380607 · Cited by 61
Zhang, Y., Bradshaw‐Pierce, E. L., Lille, A. D., Gustafson, D. L., & Anchordoquy, T. J. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21076 · Cited by 57
Self-citationLi, C., Zhao, X., Wang, Y., Yang, H., Li, H., Li, H., Tian, W., Yang, J., & Cui, J. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.01.012 · Cited by 48
Comparison of allergic reactions to pegasparaginase given intravenously versus intramuscularly
Pidaparti, M., & Bostrom, B. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23380 · Cited by 47
Complement Activation and Cell Uptake Responses Toward Polymer-Functionalized Protein Nanocapsules
Molino, N. M., Bilotkach, K., Fraser, D. A., Ren, D., & Wang, S. (2012) · Biomacromolecules · doi:10.1021/bm300083e · Cited by 46
Betker, J. L., Gomez, J., & Anchordoquy, T. J. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.07.024 · Cited by 42
Self-citationLila, A. S. A., Eldin, N. E., Ichihara, M., Ishida, T., & Kiwada, H. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.08.030 · Cited by 40
Effect of Cholesterol Nanodomains on the Targeting of Lipid-Based Gene Delivery in Cultured Cells
Xu, L., & Anchordoquy, T. J. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100097b · Cited by 38
Self-citationThe Effect of Cholesterol Domains on PEGylated Liposomal Gene Delivery In Vitro
Xu, L., Wempe, M. F., & Anchordoquy, T. J. (2011) · Therapeutic Delivery · doi:10.4155/tde.11.13 · Cited by 37
Self-citationHarvie (2000) · doi:10.1002/(sici)1520-6017(200005)89:5<652::aid-jps11>3.0.co;2-h
Cited by
Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review
Hossen, S., Hossain, M. K., Basher, M. K., Mia, M. N. H., Rahman, M. T., & Uddin, M. J. (2019) · Journal of Advanced Research · doi:10.1016/j.jare.2018.06.005 · Cited by 998
“This twist is known as the PEGylation dilemma [23,24].”
BackgroundThe Uniqueness of Albumin as a Carrier in Nanodrug Delivery
Spada, A., Emami, J., Tuszynski, J. A., & Lavasanifar, A. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00046 · Cited by 591
Biointerfacing and Applications of Cell Membrane-Coated Nanoparticles
Kroll, A. V., Fang, R. H., & Zhang, L. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00569 · Cited by 379
Immunological and Toxicological Considerations for the Design of Liposomes
Inglut, C. T., Sorrin, A. J., Kuruppu, T., Vig, S., Cicalo, J., Ahmad, H., & Huang, H.-C. (2020) · Nanomaterials · doi:10.3390/nano10020190 · Cited by 371
Cancer Cell Membrane-Coated Nanoparticles for Cancer Management
Harris, J. C., Scully, M. A., & Day, E. S. (2019) · Cancers · doi:10.3390/cancers11121836 · Cited by 278
Metadata
- Authors
- Verhoef, J. J. F., & Anchordoquy, T. J.
- Venue
- Drug Delivery and Translational Research
- Published
- 2013-09-25
- Volume
- 3
- Issue
- 6
- Pages
- 499-503
- ISSN
- 2190-393X (ISSN-L)
- 2190-3948
- OpenAlex
- W2085178300
- Cited by
- 342
- References
- 61
- FWCI
- 3.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.